Darya Zakirova

Ms. Darya Zakirova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KAKhurshid Ataniyazov
Khurshid Ataniyazov
Darya ZakirovaDarya Zakirova
Darya Zakirova
KMKhurshid Meylikov
Khurshid Meylikov
GKGulnoz Khamidullaeva
Gulnoz Khamidullaeva
GAGuzal Abdullaeva
Guzal Abdullaeva
KFKhurshid Fozilov
Khurshid Fozilov
Objective: This research investigates the correlation between nine polymorphic variants and the incidence of hypertension and its clinical manifestations in the Ellikqala District in the Republic of Karakalpakstan, Uzbekistan. This district is known as one of the most challenging areas for human habitation due to its high salinity levels in the environment, which contribute to a higher prevalence of cardiovascular diseases. Methods: This was a population-based case-control study. The study included 801 participants from the Karakalpakstan region of Uzbekistan, of which 621 were patients with essential hypertension, and the remaining 180 were the control group. Genetic analysis was conducted using multiplex qPCR with allele-specific probes. A statistical approach based on logistic regression was applied to identify their association with essential hypertension and its clinical manifestations. Logistic regression under a log-additive genetic model was used to calculate unadjusted (crude) and adjusted odds ratios and 95% confidence intervals. Stratified analyses by sex, age (<60 vs. ≥ 60 years), and BMI (<25 vs. ≥ 25 kg/m²) were performed with Bonferroni correction (k = 18 per stratification; threshold p < 2.8e-3). Results: The analysis revealed statistically significant associations between essential hypertension and six polymorphic variants after Bonferroni correction (k = 9, corrected threshold: p < 5.6e-3): AGT C521T (rs4762; OR = 0.12, 95% CI: 0.08–0.16, p-Bonferroni = 2.99e-50), AGT T704C (rs699; OR = 0.68, 95% CI: 0.54–0.86, p-Bonferroni = 1.1979e-2), AGTR2 G1675A (rs1403543; OR = 0.52, 95% CI: 0.42–0.64, p-Bonferroni = 4.76e-9), CYP11B2 C(−344)T (rs1799998; OR = 0.47, 95% CI: 0.36–0.60, p-Bonferroni = 8.97e-9), GNB3 C825T (rs5443; OR = 1.66, 95% CI: 1.27–2.18, p-Bonferroni = 1.368e-3), and NOS3 T(−786)C (rs2070744; OR = 0.27, 95% CI: 0.21–0.34, p-Bonferroni = 2.50e-27). NOS3 G894T (rs1799983) showed a nominally significant association prior to correction (OR = 0.68, 95% CI: 0.52–0.89; p = 5.069e-3), but did not survive Bonferroni adjustment (p-Bonferroni = 4.5621e-2) and should be interpreted with caution. Conclusion: Six out of nine studied polymorphic variants were associated with essential hypertension and its clinical manifestations in the Ellikqala District in the Republic of Karakalpakstan, Uzbekistan.

29 April 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
RARano Alieva
Rano Alieva
ASAleksandr Borisovich Shek
Aleksandr Borisovich Shek
AAAlisher Abdullaev
Alisher Abdullaev
HFH. G. Fozilov
H. G. Fozilov
SKSh. U. Khoshimov
Sh. U. Khoshimov
DYD. B. Yusupalieva
D. B. Yusupalieva
Aim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Progressive angina", in whom MACE (cardiovascular death, non-fatal myocardial infarction and stroke) was assessed during 5 years of follow-up. The 2-∆∆Сt value, correlating with the number of LPA KIV-2 repeats, was determined in genomic DNA using quantitative real-time polymerase chain reaction (qPCR).Results. In patients with CAD with elevated Lp(a) in the quartile 4 ≥48 mg/dL, the MACE risk was 2 times higher (relative risk 2,0; 95% confidence interval 1,04-3,87, P<0,05) than in quartile 1 ≤6 mg/dl. Moreover, among men it was 2,6 times higher (P<0,05), while in women — 1,4 times higher without significant difference. In contrast, in the study cohort, the MACE risk in quartile 1 6) (P<0,01) in men, and 3,3 times higher among women (P175 mg/dL) versus quartile 1 (<140 mg/dL) with relative risk of 0,30 (95% confidence interval 0,10-0,98, P<0,05).Conclusion. The 2-∆∆Сt value in the lower quartile associated with a low number of LPA KIV-2 repeats more accurately reflects the MACE risk in women with CAD. Also, the relative risk in women was lower in the upper quartile of apoA compared to the lower one.

29 August 2023 in Atherosclerosis
Verified
Journal Article
Closed access
RARano Alieva
Rano Alieva
ASA. Shek
A. Shek
AAAlisher Abdullaev
Alisher Abdullaev
SKS. Khoshimov
S. Khoshimov
GAG. Abdullaeva
G. Abdullaeva
AKA. Kim
A. Kim

25 May 2023 in Кардиология в Беларуси
Verified
Journal Article
Open access
Darya ZakirovaDarya Zakirova
Darya Zakirova
ГАГ.ж. Абдуллаева
Г.ж. Абдуллаева
AAAlisher Abdullaev
Alisher Abdullaev
ГХГ.а. Хамидуллаева
Г.а. Хамидуллаева
ЗМЗ.т. Машкурова
З.т. Машкурова
МАМ.и. Атоева
М.и. Атоева

15 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
AAAlisher Abdullaev
Alisher Abdullaev
Darya ZakirovaDarya Zakirova
Darya Zakirova
SKSergei Aleksandrovich Kosushkin
Sergei Aleksandrovich Kosushkin
FKFazliddin Zukhriddin ugli Khonboev
Fazliddin Zukhriddin ugli Khonboev
GAGuzal Abdullaeva
Guzal Abdullaeva
STShahlo Turdikulova
Shahlo Turdikulova
Background/Objectives: Central Asian populations are almost entirely absent from genomic reference resources, yet Uzbekistan has one of the fastest rates of growth in age-standardised type 2 diabetes (T2D) incidence. Allele frequencies at cardiometabolic risk loci are unknown, limiting the interpretation of polygenic risk scores (PRS) derived elsewhere. We aimed to characterise effect-allele frequencies in an Uzbek cohort from Tashkent and quantify divergence from 1000 Genomes panels to guide future PRS evaluation. Methods: We genotyped 171 adults from Tashkent (131 with T2D, 40 without) on a custom Agilent SureSelect panel of cardiometabolic candidate SNPs. After quality control, 1939 variants were analysed. Effect-allele frequencies were compared with 1000 Genomes Phase 3 superpopulations (EUR, SAS, EAS, AFR) using Hudson FST and Nei’s genetic distance with bootstrap 95% CIs (1000 replicates). Case–control association was assessed descriptively using both unadjusted and age- and sex-adjusted additive logistic regression, with the adjusted model as primary. Results: Reference frequencies were available for 1533 of 1939 variants (1363 at MAF ≥ 0.05). Frequencies clustered with South Asian (FST = 0.077, 95% CI 0.065–0.089) and European panels (FST = 0.086, 95% CI 0.072–0.099), which were indistinguishable (ΔFST = −0.010, 95% CI −0.022 to 0.003) and more divergent from East Asian and African panels. Divergence from the European and South Asian panels was unrelated to nominal association status (Mann–Whitney p = 0.99 and 0.57). In the primary age- and sex-adjusted analysis, no variant survived multiple-testing correction (minimum Bonferroni-adjusted and false-discovery-rate q = 0.28), consistent with the unadjusted sensitivity analysis. Conclusions: This study provides the first systematic allele-frequency reference for cardiometabolic risk loci in an Uzbek cohort from Tashkent. The profile is closest to South Asian and European panels and identifies PRS from these ancestries as priority candidates for future local validation in Central Asian settings. The case–control analysis was underpowered and is reported descriptively.